Sledge confirmed the buyout of SWM which organises meetings globally for pharmaceutical companies around clinical research.
The business has been established for 23 years and has a turnover of £10m and 20 staff.
Speaking to C&IT, Sledge CEO Robin Fawcett said: "Sledge has adopted a buy and build expansion strategy and specialism is key.
"Our strategy is to acquire businesses which have a differentiator, with a clear events connection that will enable us to expand both our capacity and capabilities. These specialist companies arguably offer some competitive protection – their services are highly targeted, possibly unique."
He added that SWM is a well-established specialist operator within the events industry.
"It has a solid client base and a key differentiator is the presence of five specialists in healthcare science on the payroll," he said
"We were very impressed by the SWM management team who will continue to lead the organisation.”
Sue White and Dr Peter Thomas from SWM, and Robin Fawcett from Sledge
SWM was founded and is run by Sue White and Dr Peter Thomas.
“The plan is that SWM Partners continues to operate from the same location, with the same personnel and offer the same quality services to our clients as it does currently,” White said.
“We feel sure that the injection of a dynamic partner such as Sledge will bring fresh ideas and innovative approaches to further enhance our offer. Peter and I will continue to work on projects as scientific program directors at SWM alongside our logistics teams.”
For more features and breaking news sign up to C&IT Magazine's daily Newstracker.